Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026
Globe Newswire•20/10/2026•08:00 ET
0
Key Highlights
- ➤Madrigal will release Q3 2026 financial results November 3 before U.S. market open
- ➤Management will host an 8 a.m. Eastern webcast to review results
- ➤Rezdiffra is approved for MASH with moderate to advanced fibrosis (F2 to F3)
CONSHOHOCKEN, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its third-quarter 2026 financial results on Tuesday, November 3, 2026, prior to the open of the U.S. financial markets.
Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.
Get started
Create a free account to read the full story.